Skip to main content

and
  1. Article

    Open Access

    Dengue virus-pandemic influenza virus co-infection results in enhanced influenza virus replication through inhibition of apoptosis

    Thomas G Voss, Mei-Chun Chen, Gena J Nichols, Somanna K Naveen in Retrovirology (2012)

  2. Article

    Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

    Thomas Geisbert and colleagues show that a cocktail of monoclonal antibodies protects cynomolgus monkeys from lethal Lassa fever virus infection, including when administration is delayed by more than a week af...

    Chad E Mire, Robert W Cross, Joan B Geisbert, Viktoriya Borisevich in Nature Medicine (2017)

  3. Article

    Establishment of an African green monkey model for COVID-19 and protection against re-infection

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for an unprecedented global pandemic of COVID-19. Animal models are urgently needed to study the pathogenesis of COVID-19 and to scre...

    Courtney Woolsey, Viktoriya Borisevich, Abhishek N. Prasad in Nature Immunology (2021)

  4. Article

    Open Access

    A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus

    Nipah and Hendra viruses are highly pathogenic bat-borne paramyxoviruses recently included in the WHO Blueprint priority diseases list. A fully registered horse anti-Hendra virus subunit vaccine has been in us...

    Thomas W. Geisbert, Kathryn Bobb, Viktoriya Borisevich, Joan B. Geisbert in npj Vaccines (2021)

  5. Article

    Open Access

    Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge

    Junin virus (JUNV) is a pathogen of biodefense importance due to its potential for aerosol transmission and mortality rates reaching 30%. Currently, there are no JUNV vaccines licensed by the United States Foo...

    Teresa E. Sorvillo, Robert W. Cross, Dylan M. Johnson, Natalie S. Dobias in npj Vaccines (2021)